NCT00511498 Effect of Nightly Versus Prn Sildenafil on Early Return of Erectile Function Following Laparoscopic Radical Prostatectomy Status COMPLETED Phase NA
NCT00510718 A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer Status COMPLETED Phase PHASE1
NCT00510224 Sandostatin for Patients With Androgen Independent Prostate Cancer Status TERMINATED Phase PHASE2
NCT00509444 Cancer Prevention and Treatment Among African American Older Adults: Treatment Trial Status COMPLETED Phase PHASE3
NCT00503984 A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients Status TERMINATED Phase PHASE1/PHASE2
NCT00503646 Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners Status UNKNOWN Phase NA
NCT00500110 Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer Status COMPLETED Phase PHASE2
NCT00499694 Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel Status COMPLETED Phase NA
NCT00499421 Evaluation of Intraprostatic Fiducial Markers For External Beam Radiation Therapy Status COMPLETED Phase N/A
NCT00499408 Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate Cancer Status COMPLETED Phase PHASE2
NCT00499174 Observation or Radical Treatment in Patients With Prostate Cancer Status TERMINATED Phase NA
NCT00498797 E3-Hormone Refractory Prostrate Cancer Taxotere Combination Status COMPLETED Phase PHASE2
NCT00496249 The Effect of Radiation on Semen Quality and Fertility in Men With Prostate Cancer Status COMPLETED Phase N/A
NCT00494546 High Versus Low Dose Supplemental External Radiation With Pd-103 for Prostate Cancer Status COMPLETED Phase PHASE3
NCT00489060 A Randomized Trial of External Beam Radiotherapy Versus Cryoablation in Patients With Localized Prostate Cancer Status COMPLETED Phase PHASE3
NCT00488982 Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC) Status COMPLETED Phase PHASE2